Search results
Results from the WOW.Com Content Network
Of those students who used such substances during the last 6 months, 39% reported their use once in this period, 24% twice, 12% three times, and 24% more than three times. [37] Consumers of neuroenhancement drugs are more willing to use them again in the future due to positive experiences or a tendency towards addiction.
Modafinil (Provigil) and pramipexole (Mirapex) have been suggested for treating cognitive dysfunction associated with bipolar depression, but evidence supporting their use is quite limited. [ 25 ] [ 26 ] In addition, riluzole , a glutamatergic drug used in ALS has been studied as an adjunct or monotherapy treatment in bipolar depression, with ...
Modafinil has been studied in the treatment of major depressive disorder. [242] [243] [244] In a 2021 systematic review and meta-analysis of randomized controlled trials of psychostimulants for depression, modafinil and other stimulants such as methylphenidate and amphetamines improved depression in traditional meta-analysis. [244]
[45] [46] Subsequent to this, there has been a resurgence in interest in stimulants for depression in recent years. [48] [49] Stimulants produce a fast-acting and pronounced but transient and short-lived mood lift. [50] [51] [48] [46] In relation to this, they are minimally effective in the treatment of depression when administered continuously.
More than a third of high school students surveyed in the United States experienced stress, anxiety or depression, and nearly a fifth said they seriously considered suicide during the COVID-19 ...
A motivation-enhancing drug, [2] [3] also known as a pro-motivational drug, [1] is a drug which increases motivation. [4] [1] Drugs enhancing motivation can be used in the treatment of motivational deficits, for instance in depression, schizophrenia, and attention deficit hyperactivity disorder (ADHD).
[3] [2] [4] The modafinil analogues are of interest in the potential treatment of a condition involving the misuse of stimulant drugs (psychostimulant use disorder or PSUD), as drugs that help increase motivation (pro-motivational agents) to treat motivational disorders, [4] [5] [6] and for treatment of neurodegenerative diseases such as ...
What addicts face is a revolving door, an ongoing cycle of waiting for treatment, getting treatment, dropping out, relapsing and then waiting and returning for more. Like so many others, Tabatha Roland, the 24-year-old addict from Burlington, wanted to get sober but felt she had hit a wall with treatment.